These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 15364232

  • 1. What is the best treatment for retinoblastoma?
    Harbour JW.
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract] [Full Text] [Related]

  • 2. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

  • 3. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

  • 4. Retinocytoma shows lack of response to chemoreduction.
    Chung J, Turaka K, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2010 Dec 22; 47 Online():e1-3. PubMed ID: 21175116
    [Abstract] [Full Text] [Related]

  • 5. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct 22; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar 22; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 7. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov 22; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 8. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun 22; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 9. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar 22; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 10. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
    Shields CL, Materin MA, Shields JA.
    Arch Ophthalmol; 2005 Nov 22; 123(11):1610-2. PubMed ID: 16286630
    [No Abstract] [Full Text] [Related]

  • 11. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr 22; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 12. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H, Khetan V, Halliday W, Héon E, Chan HS, Gallie BL.
    Arch Ophthalmol; 2009 Aug 22; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract] [Full Text] [Related]

  • 13. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan 22; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 14. Practical approach to management of retinoblastoma.
    Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA.
    Arch Ophthalmol; 2004 May 22; 122(5):729-35. PubMed ID: 15136321
    [Abstract] [Full Text] [Related]

  • 15. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun 22; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]

  • 16. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.
    Ophthalmic Genet; 2015 Jun 22; 36(3):287-9. PubMed ID: 25945688
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy for retinoblastoma.
    Chan HS, Gallie BL, Munier FL, Beck Popovic M.
    Ophthalmol Clin North Am; 2005 Mar 22; 18(1):55-63, viii. PubMed ID: 15763191
    [Abstract] [Full Text] [Related]

  • 18. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug 22; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 19. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Trans Am Ophthalmol Soc; 2004 Aug 22; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [Abstract] [Full Text] [Related]

  • 20. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
    Dai S, Dimaras H, Héon E, Budning A, Doyle J, Halliday W, Drake J, Gallie BL, Chan HS.
    Ophthalmic Genet; 2008 Sep 22; 29(3):120-5. PubMed ID: 18766991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.